Andreas Kjær

Andreas Kjær

Professor


  1. Published

    Urokinase Plasminogen Activator Receptor–PET with 68Ga-NOTA-AE105: First Clinical Experience with a Novel PET Ligand

    Skovgaard, D., Persson, M. & Kjær, Andreas, 2017, In: PET Clinics. 12, 3, p. 311-319 9 p.

    Research output: Contribution to journalReviewResearchpeer-review

  2. Published
  3. Published

    Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma

    Persson, M., Nedergaard, M. K., Brandt-Larsen, M., Skovgaard, D., Jørgensen, Jesper Tranekjær, Michaelsen, Signe Regner, Madsen, J., Lassen, Ulrik Niels, Poulsen, H. S. & Kjær, Andreas, Feb 2016, In: Journal of Nuclear Medicine. 57, 2, p. 272-278 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Urokinase-type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications

    Persson, M. & Kjær, Andreas, 3 Apr 2013, In: Clinical Physiology and Functional Imaging. 33, 5, p. 329-337 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients

    Risør, L. M., Binderup, Tina, Fosbøl, Marie Øbro, Loft, A., Friborg, Jeppe Tang & Kjær, Andreas, 2022, In: Scientific Reports. 12, 1, 11 p., 19126.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer

    Christensen, A., Kiss, K., Lelkaitis, G., Juhl, K., Persson, M., Charabi, Birgitte Wittenborg, Mortensen, Jann, Forman, Julie Lyng, Sørensen, A. L., Jensen, D. H., Kjær, Andreas & von Buchwald, Christian, 2017, In: BMC Cancer. 17, 12 p., 572.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Use and perceived utility of [18F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022

    Ambrosini, V., Caplin, M., Castaño, J. P., Christ, E., Denecke, T., Deroose, C. M., Dromain, C., Falconi, M., Grozinsky-Glasberg, S., Hicks, R. J., Hofland, J., Kjaer, A., Knigge, U. P., Kos-Kudla, B., Koumarianou, A., Krishna, B., Lamarca, A., Pavel, M., Reed, N. S., Scarpa, A. & 4 others, Srirajaskanthan, R., Sundin, A., Toumpanakis, C. & Prasad, V., 2023, In: Journal of Neuroendocrinology. 36, 1, p. 1-10 e13359.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Use of cis-[18F] fluoro-proline for assessment of exercise-related collagen synthesis in musculoskeletal connective tissue

    Skovgaard, D., Kjær, Andreas, Heinemeier, K. M., Brandt-Larsen, M., Madsen, J. & Kjær, Michael, 2011, In: P L o S One. 6, 2, p. 827-836 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published
  10. Published

    Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors

    Kjær, Andreas & Knigge, Ulrich, Jun 2015, In: Scandinavian Journal of Gastroenterology. 50, 6, p. 740-747 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 13402